Outcomes of Takotsubo cardiomyopathy in hospitalized cancer patients
| Autor: | Parijat S. Joy, Achuta Kumar Guddati, Iuliana Shapira |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Adult
Male Cancer Research medicine.medical_specialty Adolescent Cardiomyopathy 030204 cardiovascular system & hematology Malignancy Logistic regression 03 medical and health sciences Young Adult 0302 clinical medicine Risk Factors Takotsubo Cardiomyopathy Internal medicine Neoplasms medicine Humans 030212 general & internal medicine Hospital Mortality Stroke Aged Aged 80 and over business.industry Incidence (epidemiology) Incidence Cancer General Medicine Middle Aged medicine.disease Oncology Heart failure Female Complication business |
| Zdroj: | Journal of cancer research and clinical oncology. 144(8) |
| ISSN: | 1432-1335 |
| Popis: | Chemotherapy-induced cardiomyopathy is a critical complication of treatment for cancer. The emotional stress of a cancer diagnosis, ongoing chemotherapy, abnormal cancer-related wasting syndrome may contribute to cardiac morbidity in these patients. The burden of Takotsubo Cardiomyopathy (TCM) in cancer patients is unknown. The incidence of TCM and related outcomes in cancer patients was investigated in this study. The 2007–2013 National Inpatient Sample (NIS) was analyzed for patients with a prior and new diagnosis of TCM with and without malignancy. Risk factors for mortality were adjusted for associated conditions by multivariable logistic regression analysis. From 2007 to 2013, an estimated 122,855 adults were admitted with a diagnosis of TCM. In 2013, the incidence of admissions in US of patients with coexisting TCM and malignancy was 1.13%. Patients admitted for TCM with coexisting malignancy had a significantly higher mortality (13.8 vs. 2.9%, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink